Exin Therapeutics Analysis: $500K Raised
What is Exin Therapeutics?
Exin Therapeutics describes itself as an AI discovery platform for neurotherapeutics. The company says it develops target discovery tools for neural circuits across disorders, using multimodal AI to predict a drug candidate's potential across multiple neural diseases. It also states the platform is agnostic to therapeutic modality, genetic background, and supports highly localized multi-target effects.
Location
South San Francisco, California, United States
Employees
1-10
Founded
2024
Description (YC)
AI drug discovery platform for neurotherapeutics
Tag (YC)
Healthcare
Product Features & Capabilities
- target discovery platform for neurotherapeutics, utilizes multimodal AI, predicts drug candidates' potential across multiple neural disorders, multi-target effect, highly localized, agnostic to genetic background
How much Exin Therapeutics raised
Pre-Seed - $500,000
January 21, 2025Lead Investor: Y Combinator
See something that needs updating? Suggest edits to this profile.